Cardinal Health to Distribute Qiagen MDx Products to Small, Mid-sized US Hospitals | GenomeWeb

NEW YORK (GenomeWeb News) – Qiagen announced after the close of the market on Monday that Cardinal Health will make Qiagen's molecular diagnostics products available to small and mid-sized hospitals in the US not covered by Qiagen's own sales channels.

Based in Dublin, Ohio, Cardinal Health distributes pharmaceuticals and medical products to healthcare providers and has annual sales of $103 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.